Melola Discovery

← Melola Discovery

Journal SINTA 1

COMPARISON OF PLATELET ANTI AGGREGATION EFFECT ON ACUTE THROMBOTIC STROKE WITH DIABETES MELITUS AND NON-DIBETES MELITUS

Folia Medica Indonesiana · Vol. 49 No. 3 (2013)

ISSN
2355-8393, 2599-056X
Published
2013-07-01
Publisher
Airlangga University
Language
en

Abstract

Stroke was the highest cause of death and disability of all ages (15.4%) in Indonesia based on RISKESDAS 2007. Thrombotic strokeis one of ischemic stroke that had prevalence of 58.3%. Acetosal/ASA is one of anti-platelet which has been used widely as secondaryprevention for stroke meanwhile, diabetic melitus (DM) was one of the risk factor. Anti-aggregation platelet effect was measured byLight Transmission Aggregometry (LTA). The test had been done twice, before and after ASA usage for 7-10 days. 24 patients thatwere involved, hospitalized for acute thrombotic stroke at least 7-10 days, 15 from non-diabetic group and 9 from diabetic group.The results showed that there is no significant difference in demographic and risk factors for those patients (X2 test, p>0.05). Theaggregation percentage were analyzed statistically by pair t-test for pre-and post-within group, and independent t-test to comparethose two groups. The aggregation percentage of diabetic patients (n=9) was 11-48% (pre) and 7-43% (post). Meanwhile, theaggregation percentage of non-diabetic patients (n=15) was 13-64% (pre) and 13-39% (post). The usage of ASA 1 x 100 mg gave alowering aggregation percentage (t 0,05). It can be concluded that there were no difference on anti-platelet aggregation of ASAbetween diabetic and non diabetic patients with acute thrombotic stroke. For practical purpose, it can be suggested to confirmpercentage aggregation ASA with instrument that applied reliable clinical meaning.(FMI 2013;49 163-167)

Keywords

Collaboration network of the authors

7 authors · 9 co-authorship links

Hover or tap a name to highlight its co-authors. Double-click to open the author's page.

  • Universitas Airlangga
  • Affiliation unknown
  • Different organisations
  • Same organisation
  • Affiliation unknown
  • Thicker line = more joint articles · bigger circle = more articles
Show as table
Co-authorOrganisationJoint articles
Nur HadiyantiUniversitas Airlangga1
Didik HasmonoUniversitas Airlangga1
Sunarto ReksoprawiroAffiliation unknown1
Ruddy HartonoAffiliation unknown1

Affiliations come from OpenAlex; journal OAI-PMH metadata carries none. Authors without an OpenAlex ID are matched by name, which can merge or split people.

Metadata source: OpenAlex API (jurnal SINTA, ADR 0048) https://openalex.org/S4210179714, first harvested 19 Nov 2026, last seen 19 Nov 2026.
Original metadata (oai_dc)
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"><dc:title xml:lang="en">COMPARISON OF PLATELET ANTI AGGREGATION EFFECT ON ACUTE THROMBOTIC STROKE WITH DIABETES MELITUS AND NON-DIBETES MELITUS</dc:title><dc:creator>Adeltrudis Adelsa</dc:creator><dc:creator>Siti Sjamsiah</dc:creator><dc:creator>Mohammad Saiful Islam</dc:creator><dc:subject>platelet aggregation</dc:subject><dc:subject>aspirin</dc:subject><dc:subject>antiplatelet therapy</dc:subject><dc:subject>acute ischemic stroke</dc:subject><dc:subject>thrombotic stroke</dc:subject><dc:subject>diabetes mellitus</dc:subject><dc:subject>light transmission aggregometry</dc:subject><dc:subject>secondary stroke prevention</dc:subject><dc:description xml:lang="en">Stroke was the highest cause of death and disability of all ages (15.4%) in Indonesia based on RISKESDAS 2007. Thrombotic strokeis one of ischemic stroke that had prevalence of 58.3%. Acetosal/ASA is one of anti-platelet which has been used widely as secondaryprevention for stroke meanwhile, diabetic melitus (DM) was one of the risk factor. Anti-aggregation platelet effect was measured byLight Transmission Aggregometry (LTA). The test had been done twice, before and after ASA usage for 7-10 days. 24 patients thatwere involved, hospitalized for acute thrombotic stroke at least 7-10 days, 15 from non-diabetic group and 9 from diabetic group.The results showed that there is no significant difference in demographic and risk factors for those patients (X2 test, p&gt;0.05). Theaggregation percentage were analyzed statistically by pair t-test for pre-and post-within group, and independent t-test to comparethose two groups. The aggregation percentage of diabetic patients (n=9) was 11-48% (pre) and 7-43% (post). Meanwhile, theaggregation percentage of non-diabetic patients (n=15) was 13-64% (pre) and 13-39% (post). The usage of ASA 1 x 100 mg gave alowering aggregation percentage (t 0,05). It can be concluded that there were no difference on anti-platelet aggregation of ASAbetween diabetic and non diabetic patients with acute thrombotic stroke. For practical purpose, it can be suggested to confirmpercentage aggregation ASA with instrument that applied reliable clinical meaning.(FMI 2013;49 163-167)</dc:description><dc:publisher>Airlangga University</dc:publisher><dc:date>2013-07-01</dc:date><dc:type>info:eu-repo/semantics/article</dc:type><dc:identifier>http://journal.unair.ac.id/download-fullpapers-fmica49446fa7full.pdf</dc:identifier><dc:source>Folia Medica Indonesiana; Vol 49 No 3 (2013)</dc:source><dc:source>2355-8393</dc:source><dc:source>2599-056X</dc:source><dc:language>en</dc:language></oai_dc:dc>